Skip to search formSkip to main contentSkip to account menu

Halofenate

Known as: Benzeneacetic acid, 4-chloro-alpha-(3-(trifluoromethyl)phenoxy)-, 2-(acetylamino)ethyl ester, Halofenate [Chemical/Ingredient] 
A selective peroxisome proliferator-activated receptor gamma (PPAR-gamma) modulator with antilipidemic activity. Halofenate also decreases fasting… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1977
1977
In a double-blind, randomized study which lasted 48 weeks the effects of clofibrate and halofenate were compared in maturity… 
1977
1977
Summary Halofenate – free acid (HFA), the major metabolite of the hypolipidemic drug, halofenate, inhibited platelet aggregation… 
1976
1976
Rats fed a fat-free diet containing no drug, 0.02% or 0.10% halofenate, or 0.25% clofibrate for 14 days were injected… 
1976
1976
Summary Halofenate free acid (HFA), the major metabolite of the hypolipemic agent halofenate, blocked the secondary phase of… 
1976
1976
Twelve patients with Type IV hyperlipoproteinemia were treated with clofibrate and halofenate in a double blind, crossover trial… 
1976
1976
Halofenate, a serum lipid-lowering agent which inhibits binding of thyroid hormone to thyroxine-binding globulin (TBG), was… 
1976
1976
The distribution of Halofenate between the free and albumin bound forms was calculated by the use of two computer programs using… 
Highly Cited
1975
Highly Cited
1975
The effects on glycerolipid synthesis of a series of compounds including many drugs were investigated in cell-free preparations… 
1972
1972
Halofenate free acid was shown to reduce markedly the binding of salicylic acid and aspirin in human plasma. Similar, but much… 
1972
1972
MK-185 (halofenate) is a hypo-lipidemic agent which has been shown in short-term clinical trials in hyperlipidemic patients to…